Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 735 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Spectrum begins Phase 2 Glioblastoma Multiforme study

The international, multicentre, randomised trial will evaluate the safety and efficacy of lucanthone administered in combination with temozolomide (TMZ) and radiation treatment. Spectrum Pharmaceuticals chairman, president and chief